Amifostine: An Update on its Clinical Status as a Cytoprotectant in Patients with Cancer Receiving Chemotherapy or Radiotherapy and its Potential Therapeutic Application in Myelodysplastic Syndrome

Author： Culy C.R.   Spencer C.M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.5, 2001-01, pp. : 641-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darbepoetin Alfa: A Review of its Use in the Treatment of Anaemia in Patients with Cancer Receiving Chemotherapy

By Siddiqui M. Asif A.   Keating Gillian M.  

Drugs, Vol. 66, Iss. 7, 2006-01 ,pp. : 997-1012

Adis International

Access to resources Recommend Favorite

Antineoplastics: Chemotherapy and radiotherapy-induced myelodysplastic syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Therapeutic potential of IL-10 and its viral homologues: an update

By Dumont Francis J  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1551-1577

Informa Healthcare

Access to resources Recommend Favorite

Dexrazoxane: A Review of its Use as a Cardioprotective Agent in Patients Receiving Anthracycline-Based Chemotherapy

By Wiseman L.R.   Spencer C.M.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 385-403

Adis International

Access to resources Recommend Favorite

Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi

By  

Current Medicinal Chemistry, Vol. 22, Iss. 18, 2015-06 ,pp. : 2225-2235

Bentham Science Publishers

Access to resources Recommend Favorite